There’s a new vaccine about to be mass-produced.
Covid-19 vaccine maker Novavax is extremely confident its Covid-19 vaccine will receive an endorsement from the FDA early this summer.
On June 7th the FDA’s committee will gather together to evaluate whether or not Novavax is safe for the public’s use (we all know how that will go).
Chief Commercial Officer John Trizzino stated that it looks like the FDA will approve Novavax as a EUA (Emergency Use Authorization) vaccine.
The only problem with that is, there’s no emergency!
Novavax confident Covid vaccine will receive FDA authorization in June after delays https://t.co/cp07aeAazU
— CNBC International (@CNBCi) May 13, 2022
NEW: Novavax announced the submission of a request for emergency use authorization to Taiwan’s Food